Arlington, MA, United States of America

Devin Forest Reed Doud

USPTO Granted Patents = 2 

Average Co-Inventor Count = 11.9

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Devin Forest Reed Doud

Introduction

Devin Forest Reed Doud is an accomplished inventor based in Arlington, MA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neurological disorders. With a total of two patents to his name, Doud's work is paving the way for innovative therapeutic solutions.

Latest Patents

Doud's latest patents focus on decarboxylase inhibitors for treating Parkinson's disease. These patents provide inhibitors of pathogenic bacterial metabolite production and conjugates of the inhibitors. Additionally, they include pharmaceutical compositions containing the inhibitors or conjugates and methods of using the same. Another notable patent involves conjugates that include a recognition element covalently bonded to or linked through a linker to a payload. The payload can be a pharmaceutical agent, such as an antineoplastic agent, anti-infective agent, or anti-inflammatory agent, or a diagnostic agent. The patents also disclose methods of using these conjugates.

Career Highlights

Throughout his career, Doud has worked with notable companies, including Flagship Pioneering Innovations and Sail Biomedicines. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Doud has collaborated with talented individuals such as Spencer Cory Peck and Elijah Lane Bogart. These partnerships have fostered a creative environment that encourages innovation and the development of new ideas.

Conclusion

Devin Forest Reed Doud's contributions to the field of pharmaceuticals are noteworthy, particularly in the area of treatments for Parkinson's disease. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…